0001615774-16-004151.txt : 20160211 0001615774-16-004151.hdr.sgml : 20160211 20160210202457 ACCESSION NUMBER: 0001615774-16-004151 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160211 DATE AS OF CHANGE: 20160210 EFFECTIVENESS DATE: 20160211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dalix Therapeutics Inc CENTRAL INDEX KEY: 0001666562 IRS NUMBER: 475466378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-257250 FILM NUMBER: 161407592 BUSINESS ADDRESS: STREET 1: C/O 108 S. FRANKLIN AVE STREET 2: SUITE 10 CITY: VALLEY STREAM STATE: NY ZIP: 11580 BUSINESS PHONE: 5168878200 MAIL ADDRESS: STREET 1: C/O 108 S. FRANKLIN AVE STREET 2: SUITE 10 CITY: VALLEY STREAM STATE: NY ZIP: 11580 D 1 primary_doc.xml X0707 D LIVE 0001666562 Dalix Therapeutics Inc C/O DAVID LUBIN & ASSOCIATES 108 S FRANKLIN AVE STE 10 VALLEY STREAM NY NEW YORK 11580 516-887-8200 DELAWARE None None Corporation true 2015 LEONARD STERNHERM C/O DAVID LUBIN & ASSOCIATES 108 S FRANKLIN AVE STE 10 VALLEY STREAM NY NEW YORK 11580 Executive Officer Director Promoter YORAM DRUCKER C/O DAVID LUBIN & ASSOCIATES 108 S FRANKLIN AVE STE 10 VALLEY STREAM NY NEW YORK 11580 Executive Officer Director RAN ALON C/O DAVID LUBIN & ASSOCIATES 108 S FRANKLIN AVE STE 10 VALLEY STREAM NY NEW YORK 11580 Executive Officer DAVID LUBIN C/O DAVID LUBIN & ASSOCIATES 108 S FRANKLIN AVE STE 10 VALLEY STREAM NY NEW YORK 11580 Executive Officer Biotechnology No Revenues 06b false 2016-01-26 false true true If sufficient funds are raised, issuer will acquire an Israeli biotechnology company and other patented technologies. 0 6000000 750000 5250000 false 3 0 0 250000 true An undetermined amount can and will be used to pay compensation to the officers of the issuer as determined by the board. false Dalix Therapeutics Inc /s/ David Lubin David Lubin Treasurer and Secretary 2016-02-10